NuVasive, Inc. (NUVA) Stock

About NuVasive, Inc.

NuVasive, Inc. is a medical technology firm focused on creating, producing, and distributing comprehensive procedural solutions for spinal operations. The company offers a range of surgical access instruments, such as the Maxcess integrated split-blade retractor system, which facilitates less-invasive surgical approaches by significantly reducing soft tissue disruption during spinal procedures. Additionally, NuVasive manufactures specialized spinal implants designed to improve spinal fusion by optimizing the osseointegration and biomechanical characteristics of materials like porous titanium and porous polyetheretherketone. Its fixation systems are engineered to help maintain and re-establish proper patient alignment. Other offerings include cervical total disc replacement technology, used in cervical spinal fusion surgery, and advanced neuromonitoring systems. These systems leverage proprietary software for nerve detection and avoidance, complemented by comprehensive intraoperative neuromonitoring services and support. The Pulse platform, a distinctive software ecosystem, unifies various hardware technologies into a compact, integrated system within the operating room environment. Furthermore, NuVasive supplies expandable growing rod implant systems for managing early-onset scoliosis, along with diverse biologics crucial for supporting spinal fusion or bone healing. Another key product is Precice, an intramedullary implant device that employs MAGEC technology for the non-invasive lengthening of the femur and tibia. The company also offers both onsite and remote monitoring solutions for the neurological systems of patients undergoing spinal and brain-related surgical interventions. NuVasive distributes its products to a broad client base, including patients, surgeons, hospitals, and insurers, through a multi-channel sales approach encompassing independent sales agents, its own sales force, and distributors, operating across the United States and global markets. Established in 1997, NuVasive, Inc. maintains its corporate headquarters in San Diego, California.

NuVasive, Inc. is headquartered in US.

NuVasive, Inc. (NUVA) stock trades at $39.75 with a market capitalization of $2.08B. The stock is valued at a price-to-earnings (P/E) ratio of 50.96, price-to-book of 2.62, price-to-sales of 1.73. Over the past 52 weeks the stock has ranged between $35.17 and $49.53, and currently trades 19.7% below its 52-week high.

On profitability, NuVasive, Inc. generates a return on equity (ROE) of 4.86%, return on capital employed of 4.29%, an operating margin of 5.39%, a net profit margin of 3.36%.

Official website: www.nuvasive.com